drugset / Trial / NCT01263093
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to measure how much of the study drugs (clopidogrel and LY2216684) reach the blood stream and how long it takes the body to dispose of them and to determine how clopidogrel and LY2216684 might affect each other in the body. Information about any side effects that may occur will also be collected.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 300 mg | Oral |
| Subject | edivoxetine | Small molecule | 18 mg | Oral |